Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 3

eBook: US $149 Special Offer (PDF + Printed Copy): US $253
Printed Copy: US $179
Library License: US $596
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-069-7 (Print)
ISBN: 978-1-68108-068-0 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810806801150301

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimers Disease research.

The third volume of this series features research on

  • - perfusional modifications in prodromal Alzheimer's disease,
  • - BACE inhibition treatment,
  • - frontotemporal dementia caused by progranulin mutations
  • - evidence-based treatment for psychological symptoms of Alzheimer’s Disease

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK




Contributor(s):
Anne Corbett
Wolfson Centre for Age Related Diseases, Guy’s Campus
King’s College London
London
SE1 1UL
UK


Binetti G
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy


Bogdan Ignat
Faculty of General Medicine, Department of Neurology
University of Medicine and Pharmacy “Grigore T. Popa” Iasi
Romania


Clive Ballard
Wolfson Centre for Age Related Diseases, Guy’s Campus
King’s College London
London
SE1 1UL
UK


Cristian Dinu Popescu
Faculty of General Medicine, Department of Neurology
University of Medicine and Pharmacy “Grigore T. Popa” Iasi
Romania


Dan Trofin
Faculty of General Medicine, Department of Neurology
University of Medicine and Pharmacy “Grigore T. Popa” Iasi
Romania


Daniela Matei
Faculty of Biomedical Engineering, Biomedical Sciences
University of Medicine and Pharmacy “Grigore T. Popa” Iasi
Romania


Daniela Trofin
Faculty of Biomedical Engineering, Biomedical Sciences
University of Medicine and Pharmacy “Grigore T. Popa” Iasi
Romania


Frisoni G B
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy


Genevieve Evin
Florey Institute of Neuroscience and Mental Health, and Department of Anatomy and Neuroscience
The University of Melbourne
Parkville
Victoria
Australia


Jenny M. Gunnersen
Florey Institute of Neuroscience and Mental Health, and Department of Anatomy and Neuroscience
The University of Melbourne
Parkville
Victoria
Australia


Louis De Muynck
Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND)
Leuven
Belgium
/
VIB,Vesalius Research Center
Leuven
Belgium


Philip Van Damme
Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND)
Leuven
Belgium
/
VIB, Vesalius Research Center
Leuven
Belgium


Prestia A
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy


Stephanie J. Fuller
Florey Institute of Neuroscience and Mental Health, and Department of Anatomy and Neuroscience
The University of Melbourne
Parkville
Victoria
Australia


Vito Davide Moretti
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy


Zanetti O
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy




RELATED BOOKS

.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Cellular Mechanisms in Alzheimer’s Disease.